| Medical and Health Sciences | Lifetime | 222 | ES 2 | 99.99 |
| Psychology and Behavioral Sciences | Lifetime | 829 | ES 5 | 99.67 |
| Medical and Health Sciences | 2021-2025 | 154 | ES 7 | 99.97 |
| Psychology and Behavioral Sciences | 2021-2025 | 118 | ES 2 | 99.72 |
| Psychiatry and Mental health | Lifetime | 12 | ES 1 | 99.97 |
| Clinical Pharmacology | Lifetime | 109 | ES 2 | 99.55 |
| Speech and Hearing | Lifetime | 59 | ES 4 | 99.19 |
| Clinical Psychology | Lifetime | 387 | ES 3 | 99.53 |
| Pediatrics, Perinatology and Child Health | Lifetime | 746 | ES 4 | 97.64 |
| Cognitive Psychology | Lifetime | 725 | ES 2 | 97.70 |
| Philosophy of Mind, Language and Cognitive Science | Lifetime | 358 | ES 3 | 95.70 |
| Biological Psychiatry | Lifetime | 79 | ES 1 | 94.98 |
| Applied Psychology | Lifetime | 880 | ES 1 | 78.32 |
| Psychiatry and Mental health | 2021-2025 | 4 | ES 1 | 99.95 |
| Clinical Pharmacology | 2021-2025 | 12 | ES 1 | 99.20 |
| Cognitive Psychology | 2021-2025 | 54 | ES 1 | 99.02 |
| Clinical Psychology | 2021-2025 | 159 | ES 4 | 98.87 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 258 | ES 3 | 94.95 |
| Cognitive Neuroscience | 2021-2025 | 387 | ES 6 | 93.03 |
| Speech and Hearing | 2021-2025 | 118 | ES 4 | 90.21 |
| Social Psychology | 2021-2025 | 856 | ES 32 | 87.63 |
| Biological Psychiatry | 2021-2025 | 47 | ES 2 | 85.06 |
| Applied Psychology | 2021-2025 | 178 | ES 1 | 79.49 |
| Electroconvulsive Therapy Studies | Lifetime | 1 | ES 1 | 99.93 |
| Adolescent and Pediatric Healthcare | Lifetime | 4 | ES 1 | 99.87 |
| Bipolar Disorder and Treatment | Lifetime | 4 | ES 1 | 99.94 |
| Schizophrenia research and treatment | Lifetime | 11 | ES 1 | 99.92 |
| COVID-19 and Mental Health | Lifetime | 46 | ES 2 | 99.30 |
| Treatment of Major Depression | Lifetime | 21 | ES 1 | 99.73 |
| Tryptophan and brain disorders | Lifetime | 43 | ES 1 | 99.70 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 55 | ES 1 | 99.51 |
| Electrolyte and hormonal disorders | Lifetime | 33 | ES 3 | 99.30 |
| Coordination Chemistry and Organometallics | Lifetime | 104 | ES 4 | 98.91 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 281 | ES 5 | 98.42 |
| Family Caregiving in Mental Illness | Lifetime | 54 | ES 1 | 98.20 |
| Stuttering Research and Treatment | Lifetime | 36 | ES 1 | 96.69 |
| Maternal Mental Health During Pregnancy and Postpartum | Lifetime | 325 | ES 1 | 97.77 |
| Mental Health Research Topics | Lifetime | 370 | ES 3 | 98.18 |
| Functional Brain Connectivity Studies | Lifetime | 942 | ES 15 | 97.82 |
| Mental Health Treatment and Access | Lifetime | 518 | ES 8 | 97.64 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 445 | ES 9 | 96.90 |
| Long-Term Effects of COVID-19 | Lifetime | 985 | ES 55 | 94.21 |
| Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes | Lifetime | 527 | ES 3 | 97.16 |
| Digital Mental Health Interventions | Lifetime | 357 | ES 5 | 95.85 |
| Suicide and Self-Harm Studies | Lifetime | 590 | ES 9 | 95.70 |
| Mental Health and Psychiatry | Lifetime | 644 | ES 9 | 95.35 |
| Restless Legs Syndrome Research | Lifetime | 192 | ES 9 | 94.71 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 619 | ES 15 | 95.03 |
| Psychological Treatments and Disorders | Lifetime | 294 | ES 144 | 90.19 |
| Personality Disorders and Psychopathology | Lifetime | 955 | ES 23 | 90.80 |
| Cognitive Functions and Memory | Lifetime | 735 | ES 13 | 78.47 |
| Bipolar Disorder and Treatment | 2021-2025 | 3 | ES 1 | 99.92 |
| Schizophrenia research and treatment | 2021-2025 | 4 | ES 1 | 99.87 |
| Adolescent and Pediatric Healthcare | 2021-2025 | 9 | ES 1 | 98.86 |
| Electroconvulsive Therapy Studies | 2021-2025 | 2 | ES 1 | 99.80 |
| Treatment of Major Depression | 2021-2025 | 9 | ES 1 | 99.35 |
| Mental Health Research Topics | 2021-2025 | 31 | ES 1 | 99.04 |
| Tryptophan and brain disorders | 2021-2025 | 50 | ES 1 | 98.34 |
| Electrolyte and hormonal disorders | 2021-2025 | 12 | ES 1 | 97.95 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 87 | ES 1 | 96.52 |
| Functional Brain Connectivity Studies | 2021-2025 | 257 | ES 5 | 97.44 |
| Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes | 2021-2025 | 94 | ES 1 | 95.52 |
| COVID-19 and Mental Health | 2021-2025 | 718 | ES 31 | 94.52 |
| Long-Term Effects of COVID-19 | 2021-2025 | 940 | ES 61 | 93.20 |
| Maternal Mental Health During Pregnancy and Postpartum | 2021-2025 | 265 | ES 8 | 94.12 |
| Diet and metabolism studies | 2021-2025 | 953 | ES 51 | 92.24 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 217 | ES 5 | 92.51 |
| Digital Mental Health Interventions | 2021-2025 | 380 | ES 4 | 91.14 |
| Mental Health Treatment and Access | 2021-2025 | 504 | ES 11 | 90.67 |
| Mental Health and Psychiatry | 2021-2025 | 331 | ES 10 | 83.83 |
| Obsessive-Compulsive Spectrum Disorders | 2021-2025 | 447 | ES 16 | 84.00 |
| Personality Disorders and Psychopathology | 2021-2025 | 284 | ES 13 | 84.12 |
| Attention Deficit Hyperactivity Disorder | 2021-2025 | 708 | ES 27 | 81.60 |
| Child Abuse and Trauma | 2021-2025 | 970 | ES 18 | 80.19 |
| Psychotherapy Techniques and Applications | 2021-2025 | 263 | ES 6 | 79.50 |
| Pregnancy and Medication Impact | 2021-2025 | 855 | ES 10 | 73.63 |
| Coordination Chemistry and Organometallics | 2021-2025 | 299 | ES 7 | 63.17 |
| Stuttering Research and Treatment | 2021-2025 | 408 | ES 3 | 47.66 |
| Restless Legs Syndrome Research | 2021-2025 | 944 | ES 44 | 40.16 |
| Homicide, Infanticide, and Child Abuse | 2021-2025 | 836 | ES 27 | 36.15 |
| Counseling Practices and Supervision | 2021-2025 | 697 | ES 1 | 33.31 |
